Trial Profile
The Effect of FOsamprenavir/Ritonavir on the Pharmacokinetics of a Single-dose of the Antipsychotic Agent olanZApine (FORZA).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Olanzapine (Primary) ; Ritonavir (Primary)
- Indications HIV infections; Schizophrenia
- Focus Pharmacokinetics
- Acronyms FORZA
- 07 Jan 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.